本月抗生素价格无明显变动，青霉素工业盐依旧维持在历史最高价；维生素中泛酸钙由于成本端上涨、供给端缩减和需求端维持刚性，市场报价半年涨幅接近140%，其他维生素价格略有下降，继续关注泛酸钙后续实际供给格局的变化；解热镇痛药中咖啡因价格半年上涨近200%，激素等其他大宗原料药无重大变化。

本文将研究(1)基因疗法市场的现状，(2)当前参与者面临的三大挑战，(3)从事单基因和多基因遗传病研究的考虑事项，(4)单基因治疗的商业成功策略，以及(5)为获得竞争优势而寻求收购和合作关系的指导。我们的建议是基于美国在50种不同的疾病和8个不同的治疗领域进行一次给药/单次治疗“一步治愈式”基因疗法所做的100多项临床试验分析提出的。鉴于本文的重点是潜在的“根治性”疗法和多家公司争夺极小患者群体的能力，肿瘤不在我们此次分析的范围之内。尽管最近在体外自体疗法取得了进展，如CAR-T, 但许多患者仍未治愈，而且基因工程细胞疗法的群体规模大到足以支持多家公司。一些公司也在使用基因编辑等基因治疗技术治疗艾滋病等非遗传疾病。但由于这些疾病并无遗传因素，因此也不在本次分析范围之内。

The study provides insights into market metrics (unit sales and earned revenues), latest trends, market projections until 2025, and a roadmap to cutting-edge technologies that will drive the future growth of the CT market. •The study offers a detailed landscape of industry drivers, restraints, and segments conducive for market growth.

Dental burs are medical devices used in modern dentistry for surgical care and tooth restoration procedure. These are designed as a powdered rotatory instrument such as tiny drilling equipment which is equipped with cutting blades on its edges. These are used to cut hard tissues such as bone and teeth. Endodontic is the study of science related to the soft tissue surrounding the root of a tooth and dental pulp. Endodontic includes endodontic retreatment, root canal treatment, dental implants, and endodontic surgery. This study comprises products only and not services. The study estimates the revenue generated from the sales of dental burs and endodontic. The valuations comprise revenue generated from the adoption of root canal procedures by patients. The study scope focuses on dental burs and endodontic products from e-commerce websites and pharmacies. Furthermore, the report excludes revenue generated from post-sale services of dental burs and endodontic products

This study evaluates the market for digital tools for the management of behavioral health conditions, that is, behavioral health tech. The conditions included are listed below, and they are in keeping with NAMI’s definition of mental illness

Peptides are a selective, efficacious, and unique class of molecules that bind to specific cell surface receptors, triggering intracellular effects. They are short chains of amino acids linked by a peptide bond. Although they are molecularly poised between small molecules and proteins, peptides have distinctive therapeutic and biochemical properties. They represent an attractive first step in developing novel therapeutics across different areas, including oncology, metabolic, cardiovascular, infectious, endocrine, neurology, and other disorders. For decades, researchers have endeavored to comprehend intracellular protein-protein interactions (PPIs) as they play a critical role in the pathogenesis of numerous disease states. The development of constrained peptides exhibits an emerging approach that addresses challenging PPIs.

Digital health is an emerging technology, which uses connectivity, software, computing platforms, and sensors to enhance the quality of healthcare and its outcome. It increases the physical and emotional well-being of the population. This study comprises products only and not services. The study estimates the revenue generated from the sales of digital devices used for health care. The valuations comprise revenue generated from adoption of health, health information technology, wearable patch, telehealth and telemedicine by patients. The study scope focuses on digital health products for quality health care.

Endodontics is the study of science related to soft tissue surrounding the root of a tooth and dental pulp. Endodontics include endodontic retreatment, root canal treatment, dental implants and endodontic surgery. This study comprises products only and not the services. The study estimates the revenue generated from the sales of endodontic consumables. The valuations comprise revenue generated from the adoption of root canal procedures by patients. The study scope focuses on endodontics consumables for dental clinics and hospital and dental clinics. Furthermore, the report excludes revenue generated from post-sale services of endodontic consumables.

细分行业短期面临挑战，但回流可能性较小。美国虽然正在重新思考他们的供应链战略，但事实上全球的供应链正在不断地融合，形成相互联系的庞大网络。重新建立供应链和生态体系需要付出大量的时间和资金成本，考虑到新冠疫情后美国政府财政压力增大，我们认为医药先进制造回流的概率相对较小。

创新才是生产力进步本质驱动；只有创新迭出的行业，才能有翻数倍成长的个股；同时，不论是医药还是其他科技行业的成长，不会因为上游供应链的区域阻断而停滞。